US Stock MarketDetailed Quotes

UTMD Utah Medical Products

Watchlist

64.375
+0.195+0.30%

Trading Nov 21 12:28 ET

218.34MMarket Cap15.04P/E (TTM)

Utah Medical Products Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-24.70%3.86M

-43.78%2.76M

-23.70%5.28M

5.36%22.28M

-6.13%5.33M

-8.37%5.12M

1.68%4.91M

37.04%6.92M

-0.26%21.15M

13.90%5.68M

Net income from continuing operations

-9.45%3.56M

-17.79%3.45M

-6.12%3.96M

0.98%16.64M

-5.91%4.29M

-8.06%3.94M

2.34%4.2M

19.24%4.21M

11.39%16.47M

10.24%4.56M

Depreciation and amortization

-58.54%740K

-61.05%693K

-61.28%683K

-10.08%6.37M

-40.64%1.04M

2.29%1.79M

0.17%1.78M

-2.49%1.76M

-2.77%7.08M

-1.18%1.75M

Deferred tax

63.19%-53K

-26.77%-161K

-18,200.00%-183K

-72.41%-681K

-3,021.43%-409K

-17.07%-144K

10.56%-127K

99.31%-1K

-645.28%-395K

-85.42%14K

Change In working capital

11.13%-447K

-32.74%-1.28M

-15.56%749K

89.53%-233K

148.46%345K

-45.38%-503K

0.21%-962K

534.80%887K

-121.27%-2.23M

32.89%-712K

-Change in receivables

-110.11%-9K

-132.55%-83K

-111.96%-214K

532.38%2.27M

-74.34%137K

107.67%89K

-62.50%255K

409.52%1.79M

53.54%-525K

262.80%534K

-Change in inventory

-79.06%67K

205.59%170K

125.00%271K

71.53%-670K

188.54%255K

128.19%320K

-33.06%-161K

-33.99%-1.08M

-385.15%-2.35M

11.11%-288K

-Change in prepaid assets

-43.75%9K

700.00%132K

-448.00%-87K

170.31%45K

144.07%26K

-61.90%16K

-135.48%-22K

122.94%25K

20.99%-64K

-28.26%-59K

-Change in payables and accrued expense

44.61%-514K

-44.68%-1.5M

396.18%779K

-362.29%-1.88M

91.88%-73K

-148.64%-928K

34.76%-1.03M

-87.85%157K

3.77%716K

-147.66%-899K

Cash from discontinued investing activities

Operating cash flow

-24.70%3.86M

-43.78%2.76M

-23.70%5.28M

5.36%22.28M

-6.13%5.33M

-8.37%5.12M

1.68%4.91M

37.04%6.92M

-0.26%21.15M

13.90%5.68M

Investing cash flow

Cash flow from continuing investing activities

52.15%-89K

64.06%-115K

111.63%5K

21.88%-639K

-136.84%-90K

42.06%-186K

-44.14%-320K

81.86%-43K

-48.19%-818K

84.98%-38K

Capital expenditure reported

49.46%-94K

65.63%-110K

48.84%-22K

21.88%-639K

---90K

---186K

-44.14%-320K

81.86%-43K

---818K

----

Net PPE purchase and sale

--0

--27K

----

--0

----

Cash from discontinued investing activities

Investing cash flow

52.15%-89K

64.06%-115K

111.63%5K

21.88%-639K

-136.84%-90K

42.06%-186K

-44.14%-320K

81.86%-43K

-48.19%-818K

84.98%-38K

Financing cash flow

Cash flow from continuing financing activities

-375.17%-4.92M

-611.88%-7.19M

-279.69%-3.98M

24.05%-4.17M

-16.41%-1.07M

-0.29%-1.04M

71.56%-1.01M

-5,621.05%-1.05M

49.71%-5.48M

88.60%-920K

Net common stock issuance

---3.87M

---6.4M

---2.99M

--0

---2.5M

--0

Cash dividends paid

1.77%-1.05M

-1.03%-1.08M

-1.78%-1.09M

-35.38%-4.28M

-1.90%-1.07M

-1.81%-1.07M

-0.94%-1.07M

---1.07M

72.41%-3.16M

87.41%-1.05M

Proceeds from stock option exercised by employees

--0

390.00%294K

357.14%96K

-32.76%117K

--0

80.00%36K

1,400.00%60K

10.53%21K

-68.93%174K

-53.05%131K

Cash from discontinued financing activities

Financing cash flow

-375.17%-4.92M

-611.88%-7.19M

-279.69%-3.98M

24.05%-4.17M

-16.41%-1.07M

-0.29%-1.04M

71.56%-1.01M

-5,621.05%-1.05M

49.71%-5.48M

88.60%-920K

Net cash flow

Beginning cash position

5.44%89.22M

15.94%93.81M

23.74%92.87M

23.09%75.05M

26.90%88.21M

27.78%84.62M

22.83%80.91M

23.09%75.05M

18.19%60.97M

8.07%69.51M

Current changes in cash

-129.51%-1.15M

-226.79%-4.54M

-77.71%1.3M

17.73%17.48M

-11.67%4.17M

-7.93%3.9M

238.34%3.58M

20.61%5.82M

52.32%14.85M

241.55%4.72M

Effect of exchange rate changes

223.87%384K

-137.10%-46K

-1,067.57%-358K

144.20%339K

-40.42%488K

67.33%-310K

117.51%124K

-47.89%37K

-111.88%-767K

7,545.45%819K

End cash Position

0.28%88.45M

5.44%89.22M

15.94%93.81M

23.74%92.87M

26.90%88.21M

27.78%84.62M

22.83%80.91M

23.09%75.05M

Free cash flow

-23.67%3.77M

-42.37%2.65M

-23.54%5.25M

6.46%21.64M

-7.09%5.24M

-6.32%4.94M

-0.37%4.59M

42.90%6.87M

-1.56%20.33M

19.18%5.64M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-24.70%3.86M	-43.78%2.76M	-23.70%5.28M	5.36%22.28M	-6.13%5.33M	-8.37%5.12M	1.68%4.91M	37.04%6.92M	-0.26%21.15M	13.90%5.68M
Net income from continuing operations	-9.45%3.56M	-17.79%3.45M	-6.12%3.96M	0.98%16.64M	-5.91%4.29M	-8.06%3.94M	2.34%4.2M	19.24%4.21M	11.39%16.47M	10.24%4.56M
Depreciation and amortization	-58.54%740K	-61.05%693K	-61.28%683K	-10.08%6.37M	-40.64%1.04M	2.29%1.79M	0.17%1.78M	-2.49%1.76M	-2.77%7.08M	-1.18%1.75M
Deferred tax	63.19%-53K	-26.77%-161K	-18,200.00%-183K	-72.41%-681K	-3,021.43%-409K	-17.07%-144K	10.56%-127K	99.31%-1K	-645.28%-395K	-85.42%14K
Change In working capital	11.13%-447K	-32.74%-1.28M	-15.56%749K	89.53%-233K	148.46%345K	-45.38%-503K	0.21%-962K	534.80%887K	-121.27%-2.23M	32.89%-712K
-Change in receivables	-110.11%-9K	-132.55%-83K	-111.96%-214K	532.38%2.27M	-74.34%137K	107.67%89K	-62.50%255K	409.52%1.79M	53.54%-525K	262.80%534K
-Change in inventory	-79.06%67K	205.59%170K	125.00%271K	71.53%-670K	188.54%255K	128.19%320K	-33.06%-161K	-33.99%-1.08M	-385.15%-2.35M	11.11%-288K
-Change in prepaid assets	-43.75%9K	700.00%132K	-448.00%-87K	170.31%45K	144.07%26K	-61.90%16K	-135.48%-22K	122.94%25K	20.99%-64K	-28.26%-59K
-Change in payables and accrued expense	44.61%-514K	-44.68%-1.5M	396.18%779K	-362.29%-1.88M	91.88%-73K	-148.64%-928K	34.76%-1.03M	-87.85%157K	3.77%716K	-147.66%-899K
Cash from discontinued investing activities
Operating cash flow	-24.70%3.86M	-43.78%2.76M	-23.70%5.28M	5.36%22.28M	-6.13%5.33M	-8.37%5.12M	1.68%4.91M	37.04%6.92M	-0.26%21.15M	13.90%5.68M
Investing cash flow
Cash flow from continuing investing activities	52.15%-89K	64.06%-115K	111.63%5K	21.88%-639K	-136.84%-90K	42.06%-186K	-44.14%-320K	81.86%-43K	-48.19%-818K	84.98%-38K
Capital expenditure reported	49.46%-94K	65.63%-110K	48.84%-22K	21.88%-639K	---90K	---186K	-44.14%-320K	81.86%-43K	---818K	----
Net PPE purchase and sale	--0	--0	--27K	----	----	--0	--0	--0	----	----
Cash from discontinued investing activities
Investing cash flow	52.15%-89K	64.06%-115K	111.63%5K	21.88%-639K	-136.84%-90K	42.06%-186K	-44.14%-320K	81.86%-43K	-48.19%-818K	84.98%-38K
Financing cash flow
Cash flow from continuing financing activities	-375.17%-4.92M	-611.88%-7.19M	-279.69%-3.98M	24.05%-4.17M	-16.41%-1.07M	-0.29%-1.04M	71.56%-1.01M	-5,621.05%-1.05M	49.71%-5.48M	88.60%-920K
Net common stock issuance	---3.87M	---6.4M	---2.99M	--0	--0	--0	--0	--0	---2.5M	--0
Cash dividends paid	1.77%-1.05M	-1.03%-1.08M	-1.78%-1.09M	-35.38%-4.28M	-1.90%-1.07M	-1.81%-1.07M	-0.94%-1.07M	---1.07M	72.41%-3.16M	87.41%-1.05M
Proceeds from stock option exercised by employees	--0	390.00%294K	357.14%96K	-32.76%117K	--0	80.00%36K	1,400.00%60K	10.53%21K	-68.93%174K	-53.05%131K
Cash from discontinued financing activities
Financing cash flow	-375.17%-4.92M	-611.88%-7.19M	-279.69%-3.98M	24.05%-4.17M	-16.41%-1.07M	-0.29%-1.04M	71.56%-1.01M	-5,621.05%-1.05M	49.71%-5.48M	88.60%-920K
Net cash flow
Beginning cash position	5.44%89.22M	15.94%93.81M	23.74%92.87M	23.09%75.05M	26.90%88.21M	27.78%84.62M	22.83%80.91M	23.09%75.05M	18.19%60.97M	8.07%69.51M
Current changes in cash	-129.51%-1.15M	-226.79%-4.54M	-77.71%1.3M	17.73%17.48M	-11.67%4.17M	-7.93%3.9M	238.34%3.58M	20.61%5.82M	52.32%14.85M	241.55%4.72M
Effect of exchange rate changes	223.87%384K	-137.10%-46K	-1,067.57%-358K	144.20%339K	-40.42%488K	67.33%-310K	117.51%124K	-47.89%37K	-111.88%-767K	7,545.45%819K
End cash Position	0.28%88.45M	5.44%89.22M	15.94%93.81M	23.74%92.87M	23.74%92.87M	26.90%88.21M	27.78%84.62M	22.83%80.91M	23.09%75.05M	23.09%75.05M
Free cash flow	-23.67%3.77M	-42.37%2.65M	-23.54%5.25M	6.46%21.64M	-7.09%5.24M	-6.32%4.94M	-0.37%4.59M	42.90%6.87M	-1.56%20.33M	19.18%5.64M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data